HEALTH● LOWJul 2 · Jul 2, 2026, 12:28 PM
Roche lung cancer therapy beats rivals from Amgen, BMS in late-stage trial
Seeking Alpha Tech
Roche's lung cancer therapy demonstrated superior performance against rival treatments from Amgen and BMS in a late-stage clinical trial. This indicates a potential advance in lung cancer treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH35m ago'Feels like being hit by a bus': Rib remodelling beauty surgery on the riseFrance 24 [en]HEALTH38m agoExpired drugs possibly given to Nipah patients, says Keralam Health MinisterThe HinduHEALTH1h agoThe Expensive Mistake You're Making During Open Enrollment | Money Moves with Jill SchlesingerCBS NewsHEALTH2h agoActivists write open letter to Telangana CM, point at issues in govt hospitalsThe Hindu